Answers are grounded in this paper and cite their sources.
Clinical failure associated with reduced susceptibility to caspofungin has been described in Candida albicans and C. parapsilosis. We report a case of Candida krusei infection that progressed despite caspofungin therapy. Reduced microbial susceptibility to all three echinocandins (caspofungin, anidulafungin, and micafungin) was noted but was not associated with mutations in FKS1.
No takes yet. Share an insight, caveat, or question.
Hakki et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: